<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20221213056809N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2023-06-01</date_registration>
      <primary_sponsor>Islamic Azad University</primary_sponsor>
      <public_title>The effect of two types of intense interval training (HIIT) and aerobic continuity on pulmonary and cardiorespiratory functions of wrestlers recovered from corona disease</public_title>
      <acronym></acronym>
      <scientific_title>The effect of two types of intense interval training (HIIT) and aerobic continuity on pulmonary and cardiorespiratory functions of wrestlers recovered from corona disease</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2022-10-24</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>45</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/68036</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Randomization description: The subjects of the present study will include 45 recovered cultivars from Corona, which will be randomly divided into three groups. In order to place people in order, the names of each of the subjects will be written on special cards and all the names will be placed in the bag, the choices will be made one after the other. To establish the same chance among all the subjects (chance 1 to 45), after each selection, the card will be put back into the bag.</study_design>
      <phase>N/A</phase>
      <hc_freetext>COVID-19.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group 1: High-intensity interval training, each training session will include 5-12 repetitions of running for 30 seconds at full intensity and 4 minutes rest between each repetition. Intervention 2: Group 2: The main continuous aerobic training program will include running with an intensity of 60% to 75% of the maximum heart rate. It is worth mentioning that before and after the test, the participants will warm up and cool down for 5 minutes respectively. For the purpose of overload principle, two minutes were added to the main training time every week, so that in the first week, they will start training with a duration of 25 minutes and at the end of the eighth week, they will finish their activity with 40 minutes of training. Intervention 3: Control group: no activity.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Part of the data, such as information related to the main outcome or similar, can be shared.

When:
The access period starts 6 months after the results are published

To whom:
It will be available only to researchers working in academic and scientific institutions

Conditions:
Except in the above cases, no other conditions are considered

Where to obtain:
Ali Jalilian1, Tooraj Mohammad Zamani2, Vahid Kazemizadeh3*

1 Department of Physical Education and Sports Sciences, Islamabad Gharb Branch, Islamic Azad University, Islamabad Gharb, Iran.
2 Department of Physical Education and Sports Sciences, Islamabad Gharb Branch, Islamic Azad University, Islamabad Gharb, Iran.
3 Department of Exercise Physiology, Faculty of Sports Sciences, Razi University, Kermanshah, Iran.

How to obtain:
The access period starts 6 months after the results are published

Comments:
</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Tooraj Mohammad Zamani</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah Province, Eslamabad-e-Gharb, Asian Highway</address>
        <city>Islamabad Gharb</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6761783146</zip>
        <telephone>+98 83 2532 3530</telephone>
        <email>toorag.zamani@gmail.com</email>
        <affiliation>Islamic Azad University</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Vahid Kazemizadeh</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Kermanshah Province, Kermanshah, Zakariya Razi Blvd,</address>
        <city>Kermanshah</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>6714414971</zip>
        <telephone>+98 83 4522 1718</telephone>
        <email>vahid13k17@gmail.com</email>
        <affiliation>Razi University</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>All participants will be wrestlers who have recovered from the corona disease with at least 5 years of sports experience. 
None of the subjects will have a history of chronic diseases such as cardiovascular diseases, diabetes, various cancers, kidney and digestive disorders, or any type of injury or problem that prevents them from participating in physical activities.</inclusion_criteria>
      <agemin>25 years</agemin>
      <agemax>35 years</agemax>
      <gender>Male</gender>
      <exclusion_criteria>History of chronic diseases such as cardiovascular diseases, diabetes, various cancers, kidney and digestive disorders, or any type of injury or problem that prevents them from participating in physical activities.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>UO8</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Personal history of COVID-19</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
      <i_code>N/A</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group 1: High-intensity interval training, each training session will include 5-12 repetitions of running for 30 seconds at full intensity and 4 minutes rest between each repetition.</i_keyword>
      <i_keyword>Group 2: The main continuous aerobic training program will include running with an intensity of 60% to 75% of the maximum heart rate. It is worth mentioning that before and after the test, the participants will warm up and cool down for 5 minutes respectively. For the purpose of overload principle, two minutes were added to the main training time every week, so that in the first week, they will start training with a duration of 25 minutes and at the end of the eighth week, they will finish their activity with 40 minutes of training.</i_keyword>
      <i_keyword>Control group: no activity</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Pulmonary function. Timepoint: Befor and after intervention. Method of measurement: 1- Spirometry test, 2- Bruce residual test, 3- Borg pressure sensation scale questionnaire.</prim_outcome>
      <prim_outcome>Blood pressure. Timepoint: The evaluation will be carried out at 8-10 a.m. with the presence of a nursing expert from Kermanshah health center in the club of the research site. After the practice period, the post-examination stage will be followed by the candidates again before the post-examination stage, according to the points related to the pre-examination stage. In addition, the evaluations of the post-exam stage will take place 48 hours after the last training session. The evaluations of the post-test phase will be repeated in the same order as the pre-test phase. Method of measurement: Blood pressure will be recorded and measured using the Brisa device at rest and after exercise.</prim_outcome>
      <prim_outcome>Heart beat. Timepoint: The evaluation will be carried out at 8-10 a.m. with the presence of a nursing expert from Kermanshah health center in the club of the research site. After the practice period, the post-examination stage will be followed by the candidates again before the post-examination stage, according to the points related to the pre-examination stage. In addition, the evaluations of the post-exam stage will take place 48 hours after the last training session. The evaluations of the post-test phase will be repeated in the same order as the pre-test phase. Method of measurement: Heart rate measurement is done using the Polar device.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Islamic Azad University</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2022-08-23</approval_date>
        <contact_name>Kermanshah University of Medical Sciences</contact_name>
        <contact_address>Kermanshah - Shahid Beheshti Blvd., Medical Sciences Building No. 2 - Research and Technology Vice-Chancellor Kermanshah Kermanshah Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
